CoNextions device versus L-O suture repair for flexor tendon lacerations
Official title: Clinical Analysis of a Novel Flexor Tendon Repair Technique, A Prospective Randomized Trial
Run by Orlando Health, Inc. · NCT07068880 · Data updated 2026-11-12
This trial will test whether the CoNextions tendon repair device or the standard L-O suture repair leads to fewer ruptures and complications in adults aged 22 and older with Zone 2-5 flexor tendon lacerations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years to 88 Years |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Orlando Health, Inc. Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | June 18, 2024 |
| Main results expected | January 2027 |
| Study ends | July 2027 |
| Registry record updated | July 16, 2025 |
| Trial ID | NCT07068880 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 and older with acute Zone 2-5 flexor tendon lacerations who have not had prior surgery on the injured extremity and have no contraindications like metal allergy or active infection.
✕Probably not a fit
Patients under 22, those with Zone 1 injuries, prior surgery on the injured limb, active infection, inadequate blood supply, metal allergies, or incompatible metal implants would not be eligible and are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational comparison follows adults with Zone 2-5 flexor tendon lacerations who receive either the CoNextions tendon repair device or the standard L-O suture repair. Investigators will track tendon failures, ruptures, and other complications during surgery and at 2-week, 6-week, 3-month, and 6-month follow-ups. The study collects both objective measures (rupture/failure rates) and patient-reported outcomes to characterize functional recovery. Enrollment excludes patients with prior surgery on the injured limb, metal allergies, active infection, inadequate blood supply, or other contraindications.
Why it matters
Potential benefit: If successful, the CoNextions device could reduce tendon rupture rates and lower the need for repeat surgery or prolonged immobilization.
How similar studies have gone: Standard suture repairs like the L-O technique are well established, while the CoNextions device represents a relatively new approach with limited published clinical outcome data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study subjects aged 22 and older. * Subjects who sustained a Zone 2-5 flexor tendon lacerations Exclusion Criteria: * Subjects under the age of 22 at the time of consent * Subjects who sustained a Zone 1 flexor tendon injury * Subjects who have had previous surgical procedures on the injured upper extremity. * Subjects who have metal allergies * Ischemia, blood supply compromise, and/or inadequate wound coverage * Prior or current infections at or near the implant site * Conditions which tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period * Foreign-body sensitivity * The physical contact of the CoNextions TR Tendon Repair System with metal implants made of anything other than the implant grade of stainless steel, such as titanium, titanium alloys, cobalt chromium, or other dissimilar metals * Surgical procedures other than for the following indication: digital flexor tendons, digital extensor tendons proximal to the metacarpophalangeal joints (Zones 6-8) * Tendon size or surgical site access outside of specified range (Tendon Width (3.0-9.0 mm), Tendon Thickness (1.5-4.0 mm), Minimum Surgical Site Access (20 mm \[10mm/side\]) for the CoNextions TR Tendon Repair System
Where it's running
-
Orlando Health
Orlando, Florida, United States Recruiting
Study contacts
- Study coordinator: Brett Lewellyn, MD
- Email: Brett.Lewellyn@orlandohealth.com
- Phone: 321-843-5851
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EUS-guided pancreaticobiliary procedures with the RIVOS access device
This study tests how the RIVOS EUS access device performs during interventional procedures for pancreatic and bile duct problems in adults.
-
Percutaneous vs. Endoscopic Gallbladder Drainage for those who aren’t surgery candidates
This randomized trial tests two less-invasive gallbladder drainage methods to see which works better for people with acute gallbladder infection who aren’t candidates for surgery.
-
Next-Gen Fluoroscopy System vs Conventional System in Endoscopy
This trial tests whether a next-generation fluoroscopy system lowers radiation exposure for patients and staff during fluoroscopy-guided endoscopic procedures.
-
When to do endoscopic drainage for infected necrotizing pancreatitis
We will test if earlier endoscopic drainage (within the first four weeks) helps adults with infected necrotizing pancreatitis recover faster and avoid complications.
-
4-anchor internal brace repair for perilunate dislocations
We will test if a 4-anchor internal brace repair leads to better healing and fewer complications than standard K-wire fixation in adults who have had surgical fixation for a perilunate dislocation.
-
Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.